Macrophage Migration Inhibitory Factor: A Novel Biomarker in Ankylosing Spondylitis That Can Drive Spinal Fusion

被引：0
|
作者：
Ranganathan, Vidya [1 ]
Sari, Ismail [2 ]
Muralitharan, Janogini [3 ]
Anton, Ammepa [4 ]
Haroon, Nigil [2 ]
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
[2] Univ Toronto, Toronto Western Hosp, Rheumatol, Toronto, ON M5T 2S8, Canada
[3] McMaster Univ, Hamilton, ON, Canada
[4] Univ Hlth Network, Rheumatol, Toronto, ON, Canada
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2208
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Macrophage Migration Inhibitory Factor Induces Inflammation and Predicts Spinal Progression in Ankylosing Spondylitis
    Ranganathan, Vidya
    Ciccia, Francesco
    Zeng, Fanxing
    Sari, Ismail
    Guggino, Guiliana
    Muralitharan, Janogini
    Gracey, Eric
    Haroon, Nigil
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 (09) : 1796 - 1806
  • [2] THE ROLE OF MACROPHAGE MIGRATION INHIBITORY FACTOR IN ACTIVITY AND PROGRESSION OF ANKYLOSING SPONDYLITIS
    Gazar, Y.
    Hanafy, M.
    Elrefi, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1068 - 1068
  • [3] THE ROLE OF MACROPHAGE MIGRATION INHIBITORY FACTOR IN ACTIVITY AND PROGRESSION OF ANKYLOSING SPONDYLITIS
    Gazar, Y. G.
    Hanafy, M. H.
    Elrefi, M. E.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S358 - S359
  • [4] Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor
    Kozaci, Leyla Didem
    Sari, Ismail
    Alacacioglu, Ahmet
    Akar, Servet
    Akkoc, Nurullah
    MODERN RHEUMATOLOGY, 2010, 20 (01) : 34 - 39
  • [5] Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension
    DuBrock, Hilary M.
    Rodriguez-Lopez, Josanna M.
    LeVarge, Barbara L.
    Curry, Michael P.
    VanderLaan, Paul A.
    Zsengeller, Zsuzsanna K.
    Pernicone, Elizabeth
    Preston, Ioana R.
    Yu, Paul B.
    Nikolic, Ivana
    Xu, Dihua
    Thadhani, Ravi I.
    Channick, Richard N.
    Karumanchi, S. Ananth
    PULMONARY CIRCULATION, 2016, 6 (04) : 498 - 507
  • [6] Macrophage Migration Inhibitory Factor (mif): A Novel Biomarker Of Portopulmonary Hypertension
    DuBrock, H. M.
    Rodriguez-Lopez, J.
    LeVarge, B. L.
    Curry, M. P.
    Preston, I. R.
    Channick, R. N.
    Karumanchi, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [7] THE ROLE OF MACROPHAGES MIGRATION INHIBITORY FACTOR IN ANKYLOSING SPONDYLITIS ACTIVITY
    Gazar, Y. Hussein
    Hanafy, M.
    Elrefi, M.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S198 - S198
  • [8] OVEREXPRESSION OF MACROPHAGE MIGRATION INHIBITORY FACTOR IN PATIENTS WITH ANKYLOSING SPONDYLITIS AND ITS RELATION TO SEX, INFLAMMATION AND TREATMENT
    Kumar, A.
    Do, L.
    Hellman, U.
    Forsblad-d'Elia, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 716 - 716
  • [9] MiR-451 suppresses inflammatory responses in ankylosing spondylitis by targeting macrophage migration inhibitory factor
    Park, M. -C.
    Kwon, O. C.
    Lee, S. -W.
    Song, J. J.
    Park, Y. -B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (02) : 275 - 281
  • [10] MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF): A PROMISING BIOMARKER
    Grieb, Gerrit
    Merk, Melanie
    Bernhagen, Juergen
    Bucala, Richard
    DRUG NEWS & PERSPECTIVES, 2010, 23 (04) : 257 - 264
12345